Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.dragarwal.com | |
Market Cap | 1,099.05 Cr. | |
Enterprise Value(EV) | 1,119.45 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 83.72 | Trailing Twelve Months Ending 2023-06 |
Price-Earning Ratio (PE) | 27.93 | Trailing Twelve Months Ending 2023-06 |
Industry PE | 55.36 | Trailing Twelve Months Ending 2023-06 |
Book Value / Share | 265.70 | Trailing Twelve Months Ending 2023-06 |
Price to Book Value | 8.80 | Calculated using Price: 2,338.40 |
Dividend Yield | 0.13 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.47 Cr. | 4,700,000 Shares |
FaceValue | 10 | |
About Dr Agarwals Eye Hospital Ltd. | ||
Dr.Agarwal's Eye Hospital has been promoted by Dr.J.Agarwal and his family members in 1994. Though the entire family has been in the profession of providing total eye care solutions for almost five decades prior to this, through various private limited company and partnership firms, owned by the family members. The Hospital has always been at the forefront of every medical advancement in the field of Ophthalmic care in the world and has several firsts to its credit. The Hospital is engaged in conducting continuous training and research and development programs and has over a period, developed an excellent team of highly skilled Ophthalmic specialists and surgeons, to assist in its growth plans. |
1 Day |
|
+0.07% |
1 Week |
|
+2.32% |
1 Month |
|
+15.05% |
3 Month |
|
+67.83% |
6 Month |
|
+145.89% |
1 Year |
|
+137.28% |
2 Year |
|
+457.60% |
5 Year |
|
+370.85% |
10 Year |
|
+3816.67% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 14.05 | 26.67 | 0.16 | 27.78 | 21.02 | 29.55 | 26.91 | -2.60 | 36.29 | |
Return on Capital Employed (%) | 16.58 | 18.81 | 7.70 | 28.26 | 31.70 | 34.30 | 39.87 | 16.92 | 42.41 | |
Return on Assets (%) | 3.74 | 8.53 | 0.05 | 8.87 | 7.65 | 11.01 | 9.55 | -0.86 | 9.63 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 19 | 24 | 23 | 29 | 35 | 46 | 56 | 55 | 78 | 113 | |
Non Curr. Liab. | 12 | 13 | 25 | 24 | 24 | 40 | 71 | 42 | 173 | 212 | |
Curr. Liab. | 35 | 31 | 36 | 27 | 37 | 35 | 39 | 70 | 82 | 55 | |
Minority Int. | |||||||||||
Equity & Liab. | 67 | 67 | 84 | 81 | 96 | 120 | 166 | 167 | 333 | 380 | |
Non Curr. Assets | 44 | 44 | 61 | 61 | 73 | 91 | 136 | 123 | 283 | 334 | |
Curr. Assets | 23 | 23 | 24 | 20 | 23 | 30 | 30 | 44 | 50 | 47 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 67 | 67 | 84 | 81 | 96 | 120 | 166 | 167 | 333 | 380 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-06 Rs. Cr. TTM |
Net Sales | 113 | 118 | 137 | 149 | 153 | 170 | 176 | 140 | 201 | 279 | |
Other Income | 3 | 0 | 0 | 2 | 2 | 2 | 3 | 2 | 1 | 3 | |
Total Income | 116 | 118 | 137 | 150 | 156 | 172 | 179 | 142 | 202 | 282 | |
Total Expenditure | -102 | -103 | -121 | -126 | -129 | -140 | -129 | -110 | -143 | -203 | |
PBIDT | 14 | 15 | 15 | 24 | 27 | 32 | 50 | 32 | 60 | 79 | |
Interest | -4 | -4 | -5 | -4 | -3 | -4 | -9 | -7 | -7 | -6 | |
Depreciation | -6 | -6 | -11 | -9 | -10 | -11 | -21 | -19 | -20 | -20 | |
Taxation | -1 | 0 | 1 | -4 | -7 | -6 | -6 | -7 | -8 | -13 | |
Exceptional Items | |||||||||||
PAT | 2 | 6 | 0 | 7 | 7 | 12 | 14 | -1 | 24 | 39 | |
Adjusted EPS | 5 | 12 | 0 | 16 | 14 | 25 | 29 | -3 | 51 | 84 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 11 | 12 | 14 | 17 | 20 | 19 | 25 | 39 | 34 | 57 | |
Cash Fr. Inv. | -6 | -11 | -10 | -17 | -8 | -11 | -25 | -17 | -11 | -46 | |
Cash Fr. Finan. | -3 | -3 | -5 | 0 | -12 | -8 | 2 | -20 | -8 | -4 | |
Net Change | 2 | -3 | -1 | 0 | 0 | 0 | 2 | 2 | 15 | 7 | |
Cash & Cash Eqvt | 6 | 3 | 1 | 2 | 2 | 2 | 4 | 6 | 22 | 28 |
Wed, 27 Sep 2023
Closure of Trading Window Intimation of Closure of Trading Window is submitted |
Fri, 22 Sep 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report Pursuant to Regulation 44(3) of the SEBI (LODR) Regulations 2015 the voting results along with Scrutinizers Report on the resolutions passed at the 29th Annual General Meeting of the Company held on 21st September 2023 is submitted. |
Thu, 21 Sep 2023
Shareholder Meeting / Postal Ballot-Outcome of AGM Proceedings of the 29th Annual General Meeting of the Company held today the 21st day of September 2023 is submitted. |
Wed, 27 Sep 2023 |
|
|
|
|
|